Dr. Denise Yardley, a MONALEESA-2 investigator and Breast Cancer Research Programmer at Sarah Cannon Research Institute, and Shirley Mertz, the President of the Metastatic Breast Cancer Network talk with Audrey about the updated results of a targeted treatment for metastatic breast cancer from the MONALEESA-2 Trial.